Our verdict There is some evidence that the spike proteins generated by the Moderna Covid-19 vaccine leave the site of injection. There is also evidence that the spike protein on the actual virus can ...

A study headed by researchers at the Applied Biomedical Science Institute and collaborators have uncovered a region of the SARS-CoV-2 virus spike protein that induces potentially pathogenic ...

New research has uncovered a series of mutations in the SARS-CoV-2 spike protein that enhanced the virus' ability to infect the brains of mice. The findings may help scientists understand its ...

Scientists have discovered a mutation in SARS-CoV-2, the virus that causes COVID-19, that plays a key role in its ability to infect the central nervous system.

The spike protein has two main parts: the S1 domain, which varies greatly among different strains of the virus, and the S2 domain, which is highly conserved across different coronaviruses.

This means the antibodies can maintain their hold on the spike protein long enough to neutralize the virus in the body.

Recently, the U.S. Secretary of Health and Human Services announced plans to scale back federal funding for mRNA vaccine ...

Viruses with a deletion in the spike protein are better able to infect the brains of mice ‘These findings suggest there might be treatments that could work better to clear the virus from the ...